Cannabinoid receptor type 2 gene is associated with human osteoporosis.

Osteoporosis is one of the most common degenerative diseases. It is characterized by reduced bone mineral density (BMD) with an increased risk for bone fractures. There is a substantial genetic contribution to BMD, although the genetic factors involved in the pathogenesis of human osteoporosis are largely unknown. Mice with a targeted deletion of either the cannabinoid receptor type 1 (Cnr1) or type 2 (Cnr2) gene show an alteration of bone mass, and pharmacological modification of both receptors can regulate osteoclast activity and BMD. We therefore analyzed both genes in a systematic genetic association study in a human sample of postmenopausal osteoporosis patients and matched female controls. We found a significant association of single polymorphisms (P = 0.0014) and haplotypes (P = 0.0001) encompassing the CNR2 gene on human chromosome 1p36, whereas we found no convincing association for CNR1. These results demonstrate a role for the peripherally expressed CB2 receptor in the etiology of osteoporosis and provide an interesting novel therapeutical target for this severe and common disease.

[1]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[2]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[3]  M. Devoto,et al.  Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. , 2001, Human molecular genetics.

[4]  S. Ralston,et al.  Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors , 2005, Nature Medicine.

[5]  G A Churchill,et al.  Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[7]  M. Devoto,et al.  Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density , 2005, European Journal of Human Genetics.

[8]  J. Gulcher,et al.  Linkage of Osteoporosis to Chromosome 20p12 and Association to BMP2 , 2003, PLoS biology.

[9]  M. Cohen-Solal,et al.  [Genetics of osteoporosis]. , 2004, La Revue de medecine interne.

[10]  Ivar Heuch,et al.  Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. , 2004, American journal of epidemiology.

[11]  S. Grant,et al.  Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene , 1996, Nature Genetics.

[12]  Richard A. King,et al.  The genetic basis of common diseases. , 2002 .

[13]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Tatiana Foroud,et al.  Genetics of osteoporosis. , 2002, Endocrine reviews.

[15]  E. Orwoll,et al.  Phenotypic Characterization of Mice Bred for High and Low Peak Bone Mass , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Kui Zhang,et al.  Hapblock: Haplotype Block Partitioning and Tag Snp Selection Software Using a Set of Dynamic Programming Algorithms , 2022 .

[17]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Green,et al.  The Genetic Basis of Common Diseases, 2nd Edition , 2004, Human Genetics.

[19]  F. Mach,et al.  Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice , 2005, Nature.

[20]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[21]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[22]  J. Ott,et al.  First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q , 1998, European Journal of Human Genetics.